Cassel D, Rotman M, Cragoe E J, Igarashi P
Department of Biology, Technion-Israel Institute of Technology, Haifa.
Anal Biochem. 1988 Apr;170(1):63-7. doi: 10.1016/0003-2697(88)90090-5.
Amiloride and certain of its derivatives are effective inhibitors of Na/H antiporters and of epithelial Na channels. We describe a simple method for the preparation of a variety of pharmacologically active 6-iodoamiloride derivatives that are labeled with 125I at high specific radioactivity. 6-Dechloroamiloride derivatives (bearing a hydrogen atom instead of the chlorine at the 6 position of the amiloride molecule) are reacted with 125ICl, prepared by the oxidation of the iodide in Na125I preparations. The 125I-labeled derivatives are separated from free 125I by anion exchange chromatography, or purified by thin layer chromatography. Both 6-dechloroamiloride and 5-(N-alkyl)-6-dechloroamiloride derivatives can be labeled by this method, with yields varying between 10 and 70%, depending on the ICl concentration and the structure of the 5-N-alkyl group. Efficient radiolabeling at high specific radioactivity also depends on the use of freshly prepared batches of 125I. Using carrier-free 125I, [125I]6-iodoamiloride and [125I]6-iodo-5-(N-tert-butyl)amiloride were prepared with yields of 27 and 22%, respectively. Potential applications of the 125I-labeled amiloride derivatives include ligand binding and affinity labeling experiments.
氨氯吡咪及其某些衍生物是钠/氢逆向转运体和上皮钠通道的有效抑制剂。我们描述了一种制备多种具有药理活性的6-碘氨氯吡咪衍生物的简单方法,这些衍生物以高比放射性用125I标记。6-去氯氨氯吡咪衍生物(氨氯吡咪分子6位上带有氢原子而非氯原子)与通过氧化Na125I制剂中的碘化物制备的125ICl反应。通过阴离子交换色谱将125I标记的衍生物与游离的125I分离,或通过薄层色谱进行纯化。6-去氯氨氯吡咪和5-(N-烷基)-6-去氯氨氯吡咪衍生物均可通过该方法进行标记,产率在10%至70%之间变化,具体取决于ICl浓度和5-N-烷基的结构。高比放射性的有效放射性标记还取决于使用新制备的125I批次。使用无载体125I分别制备了[125I]6-碘氨氯吡咪和[125I]6-碘-5-(N-叔丁基)氨氯吡咪,产率分别为27%和22%。125I标记的氨氯吡咪衍生物的潜在应用包括配体结合和亲和标记实验。